(MedPage Today) — Telehealth company Hims & Hers said Thursday it will launch a cheaper, off-brand version of the weight-loss pill semaglutide (Wegovy), just weeks after drugmaker Novo Nordisk launched its highly anticipated reformulation…
Source link : https://www.medpagetoday.com/endocrinology/obesity/119758
Author :
Publish date : 2026-02-05 20:40:00
Copyright for syndicated content belongs to the linked Source.
